| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 229.46 | 205.68 | 174.35 | 189.90 |
| Accumulated Depreciation Total | -28.52 | -26.63 | -24.90 | -22.75 |
| Other Liabilities Total | 0.75 | 0.72 | 5.15 | 5.75 |
| Accrued Expenses | 0.90 | - | - | - |
| Common Stock Total | 3.57 | 3.57 | 3.57 | 3.57 |
| Other Current Assets Total | 76.64 | 59.42 | 34.43 | 35.16 |
| Prepaid Expenses | 0.07 | 0.09 | 0.09 | 0.20 |
| Total Assets | 229.46 | 205.68 | 174.35 | 189.90 |
| Cash | 3.41 | 2.07 | 6.13 | 2.51 |
| Total Equity | 201.21 | 177.50 | 154.80 | 156.05 |
| Long Term Investments | 25.72 | 27.08 | 20.54 | 27.25 |
| Retained Earnings( Accumulated Deficit) | 175.11 | 173.92 | 151.23 | 152.48 |
| Total Common Shares Outstanding | 0.36 | 0.36 | 0.36 | 0.36 |
| Property/ Plant/ Equipment Total- Gross | 52.75 | 49.90 | 49.18 | 47.24 |
| Tangible Book Valueper Share Common Eq | 563.00 | 496.65 | 433.24 | 436.75 |
| Total Liabilities | 28.26 | 28.18 | 19.55 | 33.84 |
| Total Debt | 3.56 | 0.00 | 0.00 | 6.04 |
| Short Term Investments | 27.54 | 25.72 | 23.88 | 21.76 |
| Cashand Short Term Investments | 30.95 | 27.79 | 30.01 | 24.27 |
| Total Receivables Net | 53.25 | 49.84 | 46.09 | 52.39 |
| Notes Payable/ Short Term Debt | 3.56 | 0.00 | 0.00 | 6.04 |
| Deferred Income Tax | 2.55 | 2.57 | 2.54 | 2.58 |
| Accounts Receivable- Trade Net | 33.64 | 28.19 | 23.42 | 38.11 |
| Property/ Plant/ Equipment Total- Net | 24.23 | 23.27 | 24.28 | 24.49 |
| Total Current Liabilities | 24.96 | 24.90 | 11.86 | 25.52 |
| Total Inventory | 15.63 | 16.72 | 12.93 | 18.79 |
| Accounts Payable | 6.62 | 13.24 | 4.21 | 8.80 |
| Other Currentliabilities Total | 13.88 | 11.66 | 7.65 | 10.68 |
| Total Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangibles Net | 0.07 | 0.06 | 0.02 | 0.02 |
| Other Long Term Assets Total | 2.31 | 1.06 | 5.61 | 6.98 |
| Note Receivable- Long Term | 0.59 | 0.35 | 0.35 | 0.35 |
| Unrealized Gain( Loss) | 22.53 | - | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 176.55 | 153.85 | 123.54 | 130.80 |
Coral Laboratories Dividend Coral Laboratories Bonus Coral Laboratories News Coral Laboratories AGM Coral Laboratories Rights Coral Laboratories Splits Coral Laboratories Board Meetings Coral Laboratories Key Metrics Coral Laboratories Shareholdings Coral Laboratories Profit Loss Coral Laboratories Cashflow Coral Laboratories Q1 Results Coral Laboratories Q2 Results Coral Laboratories Q3 Results Coral Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks